SterileAtlas Marketplaces

DiscoveryAcademic Preclinical Labs Process Dev (PDO)CDMOs

ClinicalCROs Clinical Sites Ethics / IRB Central Labs

QualityPharmacovigilance Regulatory Engineering Consultants

SupplySuppliers Equipment Packaging

DistributionLogistics Distribution Specialty Pharmacy

AccessPayers PBM

CapitalInvestors IP & Legal

SterileAtlasIntelligence Mission Control

Loading…

SterileAtlas

One marketplace for the entire drug lifecycle — global sterile pharmaceutical & biotech manufacturing intelligence.

Marketplaces

All 22 marketplaces
CDMOs
CROs
Clinical trial sites
Consultants

Opportunities

Projects, jobs & leads
Open projects
Jobs
Consulting leads

Platform

Pricing
About us
List your company
Mission Control

© 2026 SterileAtlas · Capability scores are deterministic, rules-based — not AI.

About us Terms Usage Policy Disclosures Compliance Community guidelines Privacy Cookies Refunds DPA Trust & security

Data shown across the platform is illustrative and unverified — not for vendor qualification or regulatory use.

Distribution & Commercial

Distribution

Specialty & wholesale networks

0

providers listed

Specialty and wholesale drug-distribution networks — ranked on reach, service level and launch readiness.

SearchFaceted, over real records CompareSide-by-side scorecards Post an RFxGet qualified responses CollaborateRun it in a shared room AI assistantYour organisation, this market

Scores are deterministic, rules-based — not AI.

MarketplacesDistribution

0 distributors

Sort

Distribution reach Network scale Cold-chain strength Regulatory reach Quality & compliance Market-access depth Name (A–Z)

Product categories

Prescription drugs Generics Biosimilars Vaccines Oncology Specialty pharma Controlled substances Medical devices OTC

Storage & cold chain

Refrigerated Frozen Ultra-cold CS vault

Compliance & status

GDP certified DSCSA DEA licensed Cold-chain certified Verified Accepting

Logistics

Same-day delivery8 International distribution20

Hospital network

Any hospital network ≥ 1,000 hospitals ≥ 5,000 hospitals ≥ 8,000 hospitals

On-time delivery

Any on-time %≥ 97% on-time ≥ 98% on-time ≥ 99% on-time

Ownership structure

Public10 Subsidiary6 State-owned4 Private2 Cooperative1

Revenue range

$5B – $50B9 $50B – $200B8 > $200B3

Therapeutic areas

Cardiovascular18 Primary care18 Infectious disease16 Specialty16 Oncology14 Immunology9 Rare disease4 Neurology3 Vaccines3 Other1

Country

Belgium China Germany Ireland Japan Spain Switzerland USA United Kingdom United States

Showing 0 of 0Clear filters Spain Biosimilars

No distributors match those filters.

Loosen a facet or clear the search.